MORPHOLOGICAL CHARACTERISTICS AND CLINICAL SIGNIFICANCE OF CORONARY ATHEROSCLEROTIC PLAQUE

Authors

  • Yusupova M.I. Department of Phthisiatry and Pulmonology, Microbiology, Virology, and Immunology Andijan State Medical Institute Author

Keywords:

Atherosclerosis,  lipids, stroke, inflammatory cells, plaque.

Abstract

 Atherosclerosis, which underlies most cases of coronary artery disease (CAD), is a chronic cardiovascular condition characterized by lipid deposition and persistent inflammation within the walls of large arteries. Over time, these pathological changes may lead to serious clinical outcomes, including myocardial infarction (MI) and stroke. Although atherosclerosis develops gradually over many years and is more commonly associated with older age, it remains a major cause of death worldwide, despite reductions in its incidence in certain regions. The development of atherosclerotic plaques involves the progressive accumulation of lipids, inflammatory cells, vascular smooth muscle cells, and cellular debris within the arterial intima beneath the endothelial lining. As these lesions enlarge, they may narrow the arterial lumen by more than 50%, restricting blood flow and producing symptoms such as angina, particularly during physical exertion or emotional stress. In some cases, plaques with a high lipid content and substantial inflammatory activity become vulnerable to rupture. Plaque disruption in a coronary artery can trigger thrombus formation, potentially leading to complete vessel occlusion and acute myocardial infarction. If thrombotic material travels through the circulation to the cerebral vessels, it may obstruct blood flow to the brain and cause an ischemic stroke.

References

1.Davies M. J., Woolf N., Rowles P. M., Pepper J. Morphology of the endothelium over atherosclerotic plaques in human coronary arteries. Br Heart J. 1988 Dec;60(6):459464. doi: 10.1136/hrt.60.6.459.

2.Driscoll D. M., Getz G. S. Extrahepatic synthesis of apolipoprotein E. J Lipid Res. 1984 Dec 1;25(12):13681379.

3.Eisenberg S., Friedman G., Vogel T. Enhanced metabolism of normolipidemic human plasma very low density lipoprotein in cultured cells by exogenous apolipoprotein E-3. Arteriosclerosis. 1988 Sep-Oct;8(5):480487. doi: 10.1161/01.atv.8.5.480

4.Faggiotto A., Ross R., Harker L. Studies of hypercholesterolemia in the nonhuman primate. I. Changes that lead to fatty streak formation. Arteriosclerosis. 1984 Jul-Aug;4(4):323340. doi: 10.1161/01.atv.4.4.323.

5.Fazio S., Yao Z., McCarthy B. J., Rall S. C., Jr Synthesis and secretion of apolipoprotein E occur independently of synthesis and secretion of apolipoprotein B-containing lipoproteins in HepG2 cells. J Biol Chem. 1992 Apr 5;267(10):69416945.

6.Gabuzda D. H., Hess J. L., Small J. A., Clements J. E. Regulation of the visna virus long terminal repeat in macrophages involves cellular factors that bind sequences containing AP-1 sites. Mol Cell Biol. 1989 Jun;9(6):27282733. doi: 10.1128/mcb.9.6.2728. [DOI]

7.Gordon V., Innerarity T. L., Mahley R. W. Formation of cholesterol- and apoprotein E-enriched high density lipoproteins in vitro. J Biol Chem. 1983 May 25;258(10):62026212.

Downloads

Published

2026-10-23